Who
Dean Richard Artis
EVP & Chief Scientific Officer
Company insider
Files Form 4 as: EVP & Chief Scientific Officer, Annexon.
In numbers
- Trades disclosed
- 14
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $134K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 15 Jan 2023
- Last trade
- 2 Mar 2026
- Last filed
- 4 Mar 2026
Companies traded
Activity over time
1 Feb 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K5,894 at $5.43 | filing |
| 2 Mar 2026filed 4 Mar 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $32K5,894 at $5.43 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —250,000 at $0.00 | filing |
| 19 Feb 2026filed 23 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $27K5,290 at $5.10 | filing |
| 18 Feb 2026filed 20 Feb 2026 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $27K5,290 at $5.10 | filing |
| 27 Feb 2025filed 3 Mar 2025 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —272,575 at $0.00 | filing |
| 18 Feb 2025filed 20 Feb 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Sold | $16K5,515 at $2.97 | filing |
| 27 Feb 2024filed 3 Mar 2025 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —44,963 at $0.00 | filing |
| 16 Feb 2024filed 21 Feb 2024 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —160,000 at $0.00 | filing |
| 16 Feb 2024filed 21 Feb 2024 | ANNX AnnexonBiotechnology | SEC FORM 4 Code A | —39,000 at $0.00 | filing |
| 15 Jan 2023filed 18 Jan 2023 | ANNX Annexonoption or derivative · Biotechnology | SEC FORM 4 Code A | —210,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.